Nuzenio

Revolution Medicines Partner

Revolution Medicines Partner news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 10 latest news signals 4 publisher sources 100/100 entity strength

Latest news

Almirall taps CrystalO's AI platform to discover ion channel drugs for skin disease - AllSciAllSci · Mon, 10 Aug 2026 16:51:48 GMTSobi funds Innate's phase III lacutamab trial with USD 75 million upfront deal - AllSciAllSci · Mon, 10 Aug 2026 16:50:24 GMTBeOne and Revolution Medicines partner on RAS(ON) inhibitor combinations in Asia - AllSciAllSci · Mon, 10 Aug 2026 16:11:22 GMTAcurx and Leiden University Medical Center target first inhibitor-bound MRSA PolC structure - AllSciAllSci · Mon, 10 Aug 2026 14:22:58 GMTJazz moves on Actio Bio for up to USD 1.3b to enter KCNT1-driven epilepsy market - AllSciAllSci · Mon, 10 Aug 2026 13:57:16 GMTBeOne Medicines and Revolution Medicines Partner on RAS(ON) Cancer Therapies - OncodailyOncodaily · Mon, 10 Aug 2026 13:21:02 GMT15,000 Shares in Revolution Medicines, Inc. $RVMD Bought by Avidity Partners Management LP - MarketBeatMarketBeat · Sat, 01 Aug 2026 07:47:14 GMTFDA Priority Review For Daraxonrasib Might Change The Case For Investing In Revolution Medicines (RVMD) - webull.comwebull.com · Sat, 01 Aug 2026 03:29:46 GMT

Timeline

Mon, 10 Aug 2026 16:51:48 GMTAlmirall taps CrystalO's AI platform to discover ion channel drugs for skin disease - AllSci
Mon, 10 Aug 2026 16:50:24 GMTSobi funds Innate's phase III lacutamab trial with USD 75 million upfront deal - AllSci
Mon, 10 Aug 2026 16:11:22 GMTBeOne and Revolution Medicines partner on RAS(ON) inhibitor combinations in Asia - AllSci
Mon, 10 Aug 2026 14:22:58 GMTAcurx and Leiden University Medical Center target first inhibitor-bound MRSA PolC structure - AllSci
Mon, 10 Aug 2026 13:57:16 GMTJazz moves on Actio Bio for up to USD 1.3b to enter KCNT1-driven epilepsy market - AllSci
Mon, 10 Aug 2026 13:21:02 GMTBeOne Medicines and Revolution Medicines Partner on RAS(ON) Cancer Therapies - Oncodaily

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Revolution Medicines Partner.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

4 distinct publisher/source names are currently connected to this entity page.